Lapatinib Completed Phase 1 Trials for Colorectal Cancers / Lung Cancers / Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01184482Lapatinib and Cetuximab in Patients With Solid Tumors